Literature DB >> 24015671

Crystal structure of the TRIM25 B30.2 (PRYSPRY) domain: a key component of antiviral signalling.

Akshay A D'Cruz1, Nadia J Kershaw, Jessica J Chiang, May K Wang, Nicos A Nicola, Jeffrey J Babon, Michaela U Gack, Sandra E Nicholson.   

Abstract

TRIM (tripartite motif) proteins primarily function as ubiquitin E3 ligases that regulate the innate immune response to infection. TRIM25 [also known as Efp (oestrogen-responsive finger protein)] has been implicated in the regulation of oestrogen receptor α signalling and in the regulation of innate immune signalling via RIG-I (retinoic acid-inducible gene-I). RIG-I senses cytosolic viral RNA and is subsequently ubiquitinated by TRIM25 at its N-terminal CARDs (caspase recruitment domains), leading to type I interferon production. The interaction with RIG-I is dependent on the TRIM25 B30.2 domain, a protein-interaction domain composed of the PRY and SPRY tandem sequence motifs. In the present study we describe the 1.8 Å crystal structure of the TRIM25 B30.2 domain, which exhibits a typical B30.2/SPRY domain fold comprising two N-terminal α-helices, thirteen β-strands arranged into two β-sheets and loop regions of varying lengths. A comparison with other B30.2/SPRY structures and an analysis of the loop regions identified a putative binding pocket, which is likely to be involved in binding target proteins. This was supported by mutagenesis and functional analyses, which identified two key residues (Asp(488) and Trp(621)) in the TRIM25 B30.2 domain as being critical for binding to the RIG-I CARDs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24015671      PMCID: PMC4012390          DOI: 10.1042/BJ20121425

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  61 in total

1.  Structural basis of RNA recognition and activation by innate immune receptor RIG-I.

Authors:  Fuguo Jiang; Anand Ramanathan; Matthew T Miller; Guo-Qing Tang; Michael Gale; Smita S Patel; Joseph Marcotrigiano
Journal:  Nature       Date:  2011-09-25       Impact factor: 49.962

2.  VISA is an adapter protein required for virus-triggered IFN-beta signaling.

Authors:  Liang-Guo Xu; Yan-Yi Wang; Ke-Jun Han; Lian-Yun Li; Zhonghe Zhai; Hong-Bing Shu
Journal:  Mol Cell       Date:  2005-09-16       Impact factor: 17.970

Review 3.  Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large.

Authors:  Bruce Beutler; Zhengfan Jiang; Philippe Georgel; Karine Crozat; Ben Croker; Sophie Rutschmann; Xin Du; Kasper Hoebe
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

4.  The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues.

Authors:  Seth L Masters; Shenggen Yao; Tracy A Willson; Jian-Guo Zhang; Kirsten R Palmer; Brian J Smith; Jeffrey J Babon; Nicos A Nicola; Raymond S Norton; Sandra E Nicholson
Journal:  Nat Struct Mol Biol       Date:  2005-12-20       Impact factor: 15.369

5.  Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity.

Authors:  Wenwen Zeng; Lijun Sun; Xiaomo Jiang; Xiang Chen; Fajian Hou; Anirban Adhikari; Ming Xu; Zhijian J Chen
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth.

Authors:  Tomohiko Urano; Tomoyuki Saito; Tohru Tsukui; Masayo Fujita; Takayuki Hosoi; Masami Muramatsu; Yasuyoshi Ouchi; Satoshi Inoue
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

8.  Evolutionary study of multigenic families mapping close to the human MHC class I region.

Authors:  C Vernet; J Boretto; M G Mattéi; M Takahashi; L J Jack; I H Mather; S Rouquier; P Pontarotti
Journal:  J Mol Evol       Date:  1993-12       Impact factor: 2.395

Review 9.  Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins.

Authors:  Taro Kawai; Shizuo Akira
Journal:  EMBO Mol Med       Date:  2011-08-09       Impact factor: 12.137

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  18 in total

1.  Sensor Function for Butyrophilin 3A1 in Prenyl Pyrophosphate Stimulation of Human Vγ2Vδ2 T Cells.

Authors:  Hong Wang; Craig T Morita
Journal:  J Immunol       Date:  2015-10-16       Impact factor: 5.422

2.  Identification of a second binding site on the TRIM25 B30.2 domain.

Authors:  Akshay A D'Cruz; Nadia J Kershaw; Thomas J Hayman; Edmond M Linossi; Jessica J Chiang; May K Wang; Laura F Dagley; Tatiana B Kolesnik; Jian-Guo Zhang; Seth L Masters; Michael D W Griffin; Michaela U Gack; James M Murphy; Nicos A Nicola; Jeffrey J Babon; Sandra E Nicholson
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

Review 3.  Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases.

Authors:  Liubov V Gushchina; Thomas A Kwiatkowski; Sayak Bhattacharya; Noah L Weisleder
Journal:  Pharmacol Ther       Date:  2017-10-31       Impact factor: 12.310

4.  Recurrent expansions of B30.2-associated immune receptor families in fish.

Authors:  Jaanus Suurväli; Colin J Garroway; Pierre Boudinot
Journal:  Immunogenetics       Date:  2021-12-01       Impact factor: 2.846

5.  TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction.

Authors:  Rui Pedro Galão; Harry Wilson; Kristina L Schierhorn; Franka Debeljak; Bianca S Bodmer; Daniel Goldhill; Thomas Hoenen; Sam J Wilson; Chad M Swanson; Stuart J D Neil
Journal:  PLoS Pathog       Date:  2022-05-09       Impact factor: 6.823

6.  Crystal structure and mutational analysis of the human TRIM7 B30.2 domain provide insights into the molecular basis of its binding to glycogenin-1.

Authors:  Christian J Muñoz Sosa; Federico M Issoglio; María E Carrizo
Journal:  J Biol Chem       Date:  2021-05-11       Impact factor: 5.157

7.  Crystal structure of TRIM20 C-terminal coiled-coil/B30.2 fragment: implications for the recognition of higher order oligomers.

Authors:  Christopher Weinert; Damien Morger; Aleksandra Djekic; Markus G Grütter; Peer R E Mittl
Journal:  Sci Rep       Date:  2015-06-04       Impact factor: 4.379

Review 8.  TRIM25 in the Regulation of the Antiviral Innate Immunity.

Authors:  María Martín-Vicente; Luz M Medrano; Salvador Resino; Adolfo García-Sastre; Isidoro Martínez
Journal:  Front Immunol       Date:  2017-09-22       Impact factor: 7.561

9.  FTR83, a Member of the Large Fish-Specific finTRIM Family, Triggers IFN Pathway and Counters Viral Infection.

Authors:  Christelle Langevin; Elina Aleksejeva; Armel Houel; Valérie Briolat; Corinne Torhy; Aurélie Lunazzi; Jean-Pierre Levraud; Pierre Boudinot
Journal:  Front Immunol       Date:  2017-05-26       Impact factor: 7.561

Review 10.  Targeting TRIM Proteins: A Quest towards Drugging an Emerging Protein Class.

Authors:  Francesca D'Amico; Rishov Mukhopadhyay; Huib Ovaa; Monique P C Mulder
Journal:  Chembiochem       Date:  2021-03-18       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.